The cord blood industry came into existence in the early 1990’s with the formation of several cord blood banks in the U.S. and worldwide. It has been 40 years since it was first proposed that stem and progenitor cells were present in human cord blood. [Read more…]
MSCs as an Appealing Raw Material for Use in Regenerative Medicine
Mesenchymal stem cells (MSCs) are a type of non-controversial, adult cell. When manipulated within a laboratory, then can be differentiated into the specialized cells found in skeletal tissues, such as cartilage cells (chondrocytes), bone cells (osteoblasts), and fat cells (adipocytes). In contrast, stem cells derived from embryos are capable of developing into all the different types of cells found in our body, which makes them more versatile than MSCs, but also more controversial. Induced pluripotent stem cells also exhibit greater pluripotency, but as modified cells, they come with a greater set of regulatory challenges. [Read more…]
The Remarkable Rise of iPSC-derived MSC Therapeutics: iMSCs
The rise of iPSC-derived mesenchymal stem cells (iMSCs) represents a significant evolution in regenerative medicine. iMSCs are generated by reprogramming adult somatic cells, typically fibroblasts, into induced pluripotent stem cells (iPSCs), which are then differentiated into mesenchymal stem cells (MSCs). This breakthrough technology offers several advantages over traditional MSC therapies, which are often derived from limited, patient-specific sources such as bone marrow or adipose tissue. [Read more…]
Qkine Limited and Akron Bio Announce Strategic Partnership
Collaboration to Deliver High-Quality Cytokines and Growth Factors to Enable the Advancement of Stem Cell-Based Therapeutics
Cambridge, UK and Boca Raton, FL – January 27, 2026 – Qkine Limited, a leading innovator in the development of high-quality growth factors and cytokines, and Akron Bio, a leading supplier of critical materials and services to the cell and gene therapy industry, today announced a strategic partnership focused on the joint development and global supply of ancillary materials to enable the development of stem cell-based therapeutics. [Read more…]
Stem Cell Hair Transplants in 2026: How Fat-Derived Stem Cells Are Transforming Hair Restoration
For over a decade, platelet-rich plasma (PRP) dominated the minimally invasive hair restoration space. Its appeal lay in its simplicity: draw blood, spin it, inject the growth-factor-rich plasma back into the scalp. But while PRP sparked interest and delivered early signs of improvement, its limitations have become clearer over time. Many patients require repeated sessions, results vary widely, and follicular stimulation often plateaus. [Read more…]
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 334
- Next Page »




